X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (250) 250
Publication (46) 46
Patent (43) 43
Book Review (23) 23
Conference Proceeding (15) 15
Book Chapter (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (140) 140
humans (116) 116
oncology (83) 83
immunotherapy (67) 67
animals (63) 63
cancer (61) 61
female (55) 55
mice (45) 45
immunology (43) 43
chemistry (41) 41
human necessities (41) 41
hygiene (41) 41
medical or veterinary science (41) 41
metallurgy (41) 41
microbiology (41) 41
preparations for medical, dental, or toilet purposes (41) 41
article (40) 40
beer (40) 40
biochemistry (40) 40
compositions thereof (40) 40
culture media (40) 40
enzymology (40) 40
microorganisms or enzymes (40) 40
mutation or genetic engineering (40) 40
propagating, preserving or maintaining microorganisms (40) 40
spirits (40) 40
vinegar (40) 40
wine (40) 40
middle aged (39) 39
neoplasms - immunology (37) 37
male (36) 36
aged (31) 31
adult (30) 30
expression (29) 29
lymphocytes (29) 29
tumors (29) 29
investigating or analysing materials by determining theirchemical or physical properties (26) 26
measuring (26) 26
physics (26) 26
t cells (26) 26
testing (26) 26
t-lymphocytes - immunology (25) 25
dendritic cells (23) 23
abridged index medicus (22) 22
antigens, neoplasm - immunology (21) 21
neoplasms - therapy (19) 19
t-cells (19) 19
cell biology (18) 18
cell line, tumor (18) 18
melanoma (18) 18
pancreatic neoplasms - immunology (18) 18
research (18) 18
hematology (17) 17
immunotherapy - methods (17) 17
medicine, research & experimental (17) 17
t-lymphocytes, cytotoxic - immunology (17) 17
cancer vaccines - immunology (16) 16
chemotherapy (16) 16
pancreatic cancer (16) 16
telomerase - immunology (16) 16
cd40 (15) 15
immunity (14) 14
vaccination (14) 14
antibodies, monoclonal - therapeutic use (13) 13
care and treatment (13) 13
clinical trials (13) 13
disease models, animal (13) 13
lymphocytes t (13) 13
adenocarcinoma (12) 12
cd8-positive t-lymphocytes - immunology (12) 12
in-vivo (12) 12
pancreatic neoplasms - pathology (12) 12
proteins (12) 12
responses (12) 12
telomerase (12) 12
antigens (11) 11
b-lymphocytes - immunology (11) 11
cd40 antigens - immunology (11) 11
inflammation (11) 11
lymphocytes, tumor-infiltrating - immunology (11) 11
physiological aspects (11) 11
transplantation (11) 11
treatment outcome (11) 11
analysis (10) 10
breast cancer (10) 10
breast neoplasms - immunology (10) 10
carcinoma, pancreatic ductal - immunology (10) 10
cd40 antigens - agonists (10) 10
cell (10) 10
cells (10) 10
efficacy (10) 10
gene expression (10) 10
genetic aspects (10) 10
melanoma - immunology (10) 10
metastasis (10) 10
mice, inbred c57bl (10) 10
mice, knockout (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
t-lymphocytes, regulatory - immunology (10) 10
activation (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. SY25-02 - SY25-02
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. SY21-04 - SY21-04
Journal Article
Cancer cell, ISSN 1535-6108, 5/2014, Volume 25, Issue 5, pp. 553 - 554
Oncogenic Kras is increasingly appreciated as an instigator of an inflammatory program that facilitates pancreatic cancer. In this issue of Cancer Cell ,... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2013, Volume 19, Issue 5, pp. 1035 - 1043
Journal Article
Nature Medicine, ISSN 1078-8956, 10/2015, Volume 21, Issue 10, pp. 1122 - 1123
The role of CD47-often expressed on tumor cells-as a 'don't eat me' signal that inhibits macrophage phagocytosis is well established. But new work reveals a... 
MEDICINE, RESEARCH & EXPERIMENTAL | PHAGOCYTOSIS | EAT-ME | MACROPHAGES | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL | CELL BIOLOGY | T-Lymphocytes - immunology | Animals | Neoplasms - immunology | Humans | Immunotherapy | CD47 Antigen - immunology | Care and treatment | Physiological aspects | Genetic aspects | Research | T cells | Cancer | Cancer therapies | Immune system | Tumors | Index Medicus
Journal Article
Annual review of medicine, 08/2019
CD40 is a cell-surface member of the TNF (tumor necrosis factor) receptor superfamily. Upon activation, CD40 can license dendritic cells to promote antitumor T... 
Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. SY09-01 - SY09-01
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. SY40-01 - SY40-01
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4940 - 4940
Journal Article
Cancer Cell, ISSN 1535-6108, 06/2012, Volume 21, Issue 6, pp. 822 - 835
Cancer-associated inflammation is thought to be a barrier to immune surveillance, particularly in pancreatic ductal adenocarcinoma (PDA). Gr-1 CD11b cells are... 
OVEREXPRESSION | MICROENVIRONMENT | ONCOLOGY | DUCTAL ADENOCARCINOMA | INTERLEUKIN-1-BETA | MICE | SUPPRESSOR-CELLS | INDUCTION | DIFFERENTIATION | MAMMARY CARCINOMAS | MOUSE MODELS | CELL BIOLOGY | Immunohistochemistry | Adenocarcinoma - pathology | CD8-Positive T-Lymphocytes - pathology | Pancreatic Neoplasms - metabolism | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Inflammation - metabolism | Adenocarcinoma - metabolism | RNA Interference | T-Lymphocytes - metabolism | Myeloid Cells - immunology | CD8-Positive T-Lymphocytes - metabolism | T-Lymphocytes - pathology | Carcinoma, Pancreatic Ductal - immunology | CD11b Antigen - immunology | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Receptors, Chemokine - metabolism | Mice, Transgenic | Inflammation - immunology | Receptors, Chemokine - immunology | Carcinoma, Pancreatic Ductal - pathology | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Mice, Knockout | Tumor Microenvironment - immunology | Models, Immunological | Animals | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Pancreatic Neoplasms - immunology | Cell Line, Tumor | Myeloid Cells - metabolism | T-Lymphocytes - immunology | Mice | CD11b Antigen - metabolism | Myeloid Cells - pathology | CD8-Positive T-Lymphocytes - immunology | Medical colleges | Analysis | Pancreatic cancer | Oncology, Experimental | Genetically modified organisms | Inflammation | Macrophage colony stimulating factor | Research | T cells | Tumors | Cancer | Index Medicus | granulocyte-macrophage colony stimulating factor | myeloid cells | T lymphocyte | carcinoma | pancreas
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1356 - 1356
Journal Article
Cancer Cell, ISSN 1535-6108, 05/2014, Volume 25, Issue 5, pp. 553 - 554
Oncogenic Kras is increasingly appreciated as an instigator of an inflammatory program that facilitates pancreatic cancer. In this issue of , McAllister and... 
MICE | ONCOLOGY | CANCER | TH17 CELLS | CELL BIOLOGY | Interleukin-17 - metabolism | Animals | Epithelial Cells - metabolism | Hematopoietic System - metabolism | Pancreatic Neoplasms - metabolism | Humans | Proto-Oncogene Proteins p21(ras) - metabolism | Tumors | Index Medicus
Journal Article
Journal Article
Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7547, pp. 373 - 377
Journal Article
Science, ISSN 0036-8075, 3/2011, Volume 331, Issue 6024, pp. 1612 - 1616
Immunosuppressive tumor microenvironments can restrain antitumor immunity, particularly in pancreatic ductal adenocarcinoma (PDA). Because CD40 activation can... 
T lymphocytes | Bacteriophages | REPORTS | Agonists | Leukocytes | Macrophages | Lesions | Immunity | Lymph nodes | Medical schools | Tumors | TRIAL | ACTIVATION | THERAPY | IMMUNOTHERAPY | TOLERANCE | MULTIDISCIPLINARY SCIENCES | VACCINE | ANTIBODY | T-CELL HELP | CANCER | CHEMOTHERAPY | Carcinoma, Pancreatic Ductal - secondary | Immunologic Surveillance | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Tumor Microenvironment | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Pancreatic Neoplasms - drug therapy | Young Adult | Deoxycytidine - therapeutic use | Antineoplastic Agents - adverse effects | Adult | Female | Carcinoma, Pancreatic Ductal - immunology | Macrophages - immunology | Disease Models, Animal | Pancreatic Neoplasms - pathology | CD40 Antigens - agonists | Carcinoma, Pancreatic Ductal - pathology | Macrophage Activation | Carcinoma, Pancreatic Ductal - drug therapy | Disease-Free Survival | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pancreatic Neoplasms - immunology | T-Lymphocytes - immunology | Aged | Mice | Antibodies, Monoclonal - metabolism | CD40 Antigens - immunology | Deoxycytidine - analogs & derivatives | Care and treatment | Carcinoma | Pancreatic cancer | Antigen presenting cells | Development and progression | Genetic aspects | Cancer | Human subjects | Monoclonal antibodies | Chemotherapy | Immunology | Rodents | Index Medicus | Effectiveness | Surveillance | Genetic engineering | PDA | Patients
Journal Article